Bristol-Myers Squibb Company (BMY)

pos +0.00
Today's Range: 75.00 - 75.98 | BMY Avg Daily Volume: 5,948,400
Last Update: 07/22/16 - 4:02 PM EDT
Volume: 0
YTD Performance: 10.02%
Open: $0.00
Previous Close: $75.50
52 Week Range: $51.82 - $77.12
Oustanding Shares: 1,669,307,273
Market Cap: 126,032,699,112
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 7 6
Moderate Buy 1 1 1 1
Hold 7 7 6 6
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2
Mean Rec. 2.32 2.32 2.28 2.37
Latest Dividend: 0.38
Latest Dividend Yield: 2.01%
Dividend Ex-Date: 06/29/16
Price Earnings Ratio: 37.56
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
37.56 81.20 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
7.07% 9.10% 68.18%
Revenue 4.30 -0.10 -0.02
Net Income -19.60 -0.30 -0.13
EPS -22.50 -0.20 -0.07
Earnings for BMY:
Revenue 16.56B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $0.67 $0.64 $2.63 $3.31
Number of Analysts 10 6 12 12
High Estimate $0.70 $0.68 $2.70 $3.70
Low Estimate $0.64 $0.61 $2.53 $2.79
Prior Year $0.53 $0.39 $2.01 $2.63
Growth Rate (Year over Year) 26.60% 64.10% 30.64% 25.90%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Let me give you the unassailable themes.
Brexit wasn't the cataclysmic event many pundits wailed about, and while there is still uncertainty, the market is showing its resilience.

It's Not Business as Usual Real Money Pro($)

The more dire the creditworthiness, the more central banks are buying up a country's sovereign debt. Sovereign credit downgrades are multiply
One side lied, one side barely tried, the people voted for economic suicide, but it will not stick.  
This debate is not about EU control of Britain.
Large biotech stocks are still at their cheapest valuations since 2011.
This is the group that is the most dangerous politically.
And the usual suspects need to bottom or keep gaining.
The stock is gaining today with the help of a nice jump in volume.


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.